Slideshow

EULAR 2020 Roundup: Men Get Sjogren's Too

In this slideshow, we highlight some presentations from EULAR 2020 we thought would interest you. The list includes a study that shows primary Sjogren’s syndrome affects men as well, and it highlights findings from a study that shows voclosporin was effective in treating lupus neprhitis in Latinas, a group disproportionately affected by the condition. More in this slideshow.

In this slideshow, we highlight some presentations from EULAR 2020 we thought would interest you. The list includes a study that shows primary Sjogren’s syndrome affects men as well, and it highlights findings from a study that shows voclosporin was effective in treating lupus neprhitis in Latinas, a group disproportionately affected by the condition. More in this slideshow.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Related Content
Multi-Stakeholder Collaboration Makes 2024 a Landmark Year for Biosimilars | Credit: HCPLive.com
December 26th 2024

Multi-Stakeholder Collaboration Makes 2024 a Landmark Year for Biosimilars

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria
December 21st 2024

CASPAR Criteria May Identify More Patients With Juvenile PsA Than ILAR Criteria

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Credit: US Food and Drug Administration
December 17th 2024

FDA Accepts New Drug Application for TNX-102 SL in Fibromyalgia

Chelsie Derman
HCPLive Rheumatology Month in Review
December 7th 2024

Rheumatology Month in Review: November 2024

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.